1

Get in touch with us

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Address

4953 Vine Street
San Diego, CA 92465

Office hours

Workdays at
9:00am – 6:00pm
Call us
(815) 555-5555

Let’s get connected

Get in Touch

Honesty – Integrity – Experience

.

The mission of The Atticus Group is to partner with medical technology and molecular diagnostic companies to assist in the development of comprehensive strategic plans and tactical marketing solutions which drive revenue growth. Founded in Portsmouth, New Hampshire in 2009, our specialty is working with U.S. and European-based companies who have developed novel medical technologies or molecular diagnostic tests targeted towards the U.S. and select global markets. Our broad experience providing strategic insight and creative marketing solutions for innovative medical technology companies allows The Atticus Group to tailor our efforts to meet our customers needs.


 

Meet the Team

.

Larry Yost, R.Ph.

Founder and Managing Partner

With over 30 years of combined experience for domestic and international medical device, pharmaceutical, and molecular diagnostic companies, Larry Yost offers our entrepreneurial and large company clients the expertise required for a wide range of their strategic market development and tactical marketing needs.

In addition to his role with The Atticus Group, Larry is also currently the General Manager for IntegraGen, Inc., a Cambridge, Massachusetts subsidiary of IntegraGen SA, a French based genomics and molecular diagnosis company with focuses in the fields of oncology and autism. Prior to founding The Atticus Group, Larry was the Vice-President of Sales and Marketing at Expanding Orthopedics, Inc., a start-up medical device company focused on the development of innovative spinal implant for patients with poor bone quality and novel solutions for fracture repair in orthopedic trauma patients.

Previously, Larry was Director of Marketing at Salient Surgical Technologies (formerly TissueLink Medical and now Medtronic Advanced Energy), an early stage company with a proprietary radiofrequency technology used to reduce blood loss during total joint replacement, spine surgery, and solid organ resection. While at Salient, his responsibilities included the commercialization of the Aquamantys® System in the U.S. and selected European countries as well as the development and implementation of strategic programs designed to communicate the clinical and economic value of the Company’s technology to its customers.

Before joining Salient, Larry was Director of Marketing at Vasca, Inc., a start-up medical device company with innovative implantable dialysis-access technology. While at Vasca, Larry was responsible for developing and implementing the company’s marketing and reimbursement strategies with the latter resulting in the successful receipt of a unique CPT code and incremental reimbursement coverage for the Company’s proprietary technology. Prior to his time at Vasca, Larry was a member of the global marketing team at Baxter Healthcare’s Renal Division where his focus was the development of clinical marketing programs supporting the company’s dialysis product lines in the U.S., Japan, Asia, and Europe. Larry began his career in pharmaceutical sales at The Upjohn Company followed by several differing roles within the Company’s Medical Sciences Liaison organization.

Larry is a graduate of the Purdue University School of Pharmacy and currently maintains his Pharmacist license in the State of Indiana.

Click here to view Larry Yost’s LinkedIn profile

 


.

Meg Saunders

Creative Director, Print and Digital Media

Meg Saunders is The Atticus Group’s Creative Director for Print and Digital Media. Meg is responsible for the creative design and layout of promotional and educational print materials as well as web-based content for our clients. She has considerable creative talent and expertise based on her eight years of experience in the design industry. Meg understands all angles of the design process and has an appreciation of client needs relative to assisting them to achieve their marketing goals.

Prior to joining the Atticus Group, Meg worked as a designer and art director for a variety of companies and organizations including Boston University, FingerPaint Marketing and the Ayco Group. Her projects ranged from company branding, business collateral, magazine layout, posters, mailers and website design and development.

Meg has a Bachelor of Arts in Graphic Design from the Art Institute of Portland and a Master of Fine Arts in Graphic Design from Boston University. In addition to her role with The Atticus Group, Meg will also continue to teach web design at the New Hampshire Institute of Art located in Manchester, New Hampshire.

Click here to view Meg Saunder’s LinkedIn profile

 


.

Mart Pearson

Strategic Business Consultant

Mart Pearson, Founding Partner Valmolina Group Consulting, LLC. provides consultative support to The Atticus Group and its clients related to international business development activities and strategic translational initiatives focusing on the commercialization of technologies discovered and initially developed in an academic research environment. Mart has more than 25 years of experience with medical device startups and has an extensive experience with the introduction of new technologies. Top to bottom responsibilities have included the analysis of market opportunity; prioritization and targeting of strategic initiatives, identification and management of key opinion leaders; development of clinical evidence; support for pre-market studies and management of post-market clinical studies; creation of legal entities; management of product distribution logistics; and the identification of appropriate direct and distribution sales channels, including the selection and management of distributor networks.

Previously, Mart was Vice-President of Europe for Cohera Medical, an early stage medical technology company that developed a line of surgical adhesives and sealants based on a unique chemical design that is resorbable, non-toxic, easy-to-use, and forms a strong bond between tissue layers. Prior to this he was an International Vice-President at Salient Surgical Technologies (formerly TissueLink Medical and now Medtronic Advanced Energy), an early stage company with a proprietary radiofrequency technology used to reduce blood loss during total joint replacement, spine surgery, and solid organ resection. Before joining TissueLink Mart was responsible for setting up one of the first international subsidiaries of STERIS Corporation in Italy. The company’s focus was a low temperature liquid sterilization system for heat sensitive surgical instruments.

Mart’s consulting activities are based in both Portsmouth, New Hampshire and in Northern Italy. He has a Bachelor of Arts in Philosophy, Economics, and Languages from Pomona College.

Click here to view Mart Pearson’s LinkedIn profile

 


 

Click here to see what people are saying about us.

What stage of product development are you at?

The mission of The Atticus Group is to partner with medical technology and molecular diagnostic companies to assist in the development of comprehensive strategic plans and tactical marketing solutions which drive revenue growth. Our specialty is working with companies who have novel medical technologies or diagnostic tests that are targeted towards the U.S. and select global markets. Our broad experience providing strategic insight and creative marketing solutions for innovative medical technology companies allows The Atticus Group to tailor our efforts to meet our customers needs.

Which of the below represents where you are at in the product life cycle? Click on the appropriate box to learn more about how The Atticus Group can help support your needs.

Is your product in the development stage?

Just getting started with an innovative new technology?

Whether you’ve got an initial prototype or are still in the design phase, The Atticus Group can help with sound advice for developing an initial business plan, defining the market for your device and helping you to address questions that may aid in your quest for future funding.

Are you preparing for product launch?

Ready to lay the groundwork for a successful product launch?

You’ve designed an innovative medical technology, confirmed its efficacy in clinical trials and are about to clear your last regulatory hurdles. You’re about to send your product out into the world – The Atticus Group can help you with pricing strategies, financial projections, development of economic messaging and more. Wherever you are in the process of commercializing your product, The Atticus Group can offer professional assistance with business development and creative marketing solutions that will help you make the most of your product’s strengths in today’s complex and crowded healthcare marketplace.

Is your product commercialized?

Need help gaining market adoption of your technology?

You’ve cleared all of the regulatory hurdles and have commercialized your technology – now you want to grow your business. The Atticus Group can help with tactical marketing solutions which can assist you in gaining a foothold in your targeted market segments and to drive product acceptance. Wherever you are in the process of commercializing your product, The Atticus Group can offer professional assistance that will help you make the most of your product’s strengths in today’s complex and crowded healthcare marketplace.